AMCNO Provides Proponent Testimony on Sub. HB 124

The Senate Health and Human Services Committee heard proponent testimony last week on Substitute HB 124 - Patient with certain venereal diseases–prescribe for sexual partner. The AMCNO supplied written testimony in support of this important legislation, and we participated in an interested party meeting following the committee hearing. The legislation would allow a drug for a sexual partner of a patient diagnosed with chlamydia, gonorrhea, or trichomoniasis to be prescribed antibiotics without the partner being examined. Ohio is one of only four states that will not allow the practice of Expedited Partner Therapy (EPT) to occur when needed. EPT is the practice of providing prescription antibiotics to one or more sexual partners of a patient who has been examined and diagnosed with a sexually transmitted infection, without the physician examining and diagnosing the partner(s). 

EPT involves the use of established protocols from the Centers for Disease Control and Prevention. In addition, studies from other states have illustrated the reduction in both chlamydial and gonorrheal infection rates among young adults when EPT has been utilized. The bill would permit up to two prescriptions to be prescribed for partners of the patient diagnosed. The bill also includes guidelines for partner education and recommendations for when the partner should seek medical treatment. 

Dr. Laura David, an AMCNO board member, testified in support of Sub. HB 124 on behalf of the Ohio Chapter of the American Congress of Obstetricians and Gynecologists (Ohio ACOG). Sub. HB 124 marks the first time that two physicians have co-sponsored legislation in the Ohio House.

View a snapshot on our Twitter feed or Facebook page.

The Pollen Line is now closed. See you in the spring!

Grass: 0
Mold: 0

Weed: 0

Tree: 0

Ragweed: 0

AMCNO on Twitter